2019 ACC专家共识决策路径:心力衰竭住院患者的风险评估,管理和临床路径

2019-09-10 美国心脏病学会 J Am Coll Cardiol. 2019 Sep 10.

2019年9月,美国心脏病学会(ACC)发布了心力衰竭住院患者的风险评估,管理和临床路径共识。文章主要由5个节点构成:入院,检查路径,口服药物治疗,出院,首次随访。

中文标题:

2019 ACC专家共识决策路径:心力衰竭住院患者的风险评估,管理和临床路径

英文标题:

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee.

发布机构:

美国心脏病学会

发布日期:

2019-09-10

简要介绍:

2019年9月,美国心脏病学会(ACC)发布了心力衰竭住院患者的风险评估,管理和临床路径共识。文章主要由5个节点构成:入院,检查路径,口服药物治疗,出院,首次随访。

 

拓展指南:心力衰竭相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ACC专家共识决策路径:心力衰竭住院患者的风险评估,管理和临床路径)] GetToolGuiderByIdResponse(projectId=1, id=bb8951c001800ac7, title=2019 ACC专家共识决策路径:心力衰竭住院患者的风险评估,管理和临床路径, enTitle=2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee., guiderFrom=J Am Coll Cardiol. 2019 Sep 10., authorId=null, author=, summary=2019年9月,美国心脏病学会(ACC)发布了心力衰竭住院患者的风险评估,管理和临床路径共识。文章主要由5个节点构成:入院,检查路径,口服药物治疗,出院,首次随访。 , cover=, journalId=null, articlesId=null, associationId=849, associationName=美国心脏病学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Sep 10 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年9月,美国心脏病学会(ACC)发布了心力衰竭住院患者的风险评估,管理和临床路径共识。文章主要由5个节点构成:入院,检查路径,口服药物治疗,出院,首次随访。 </P> <P> </P>拓展指南:<strong>与<font color=red>心力衰竭</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=da43f1c001e717ad" title="中国成人心力衰竭超声心动图规范化检查专家共识" target=_blank>中国成人心力衰竭超声心动图规范化检查专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0e4f91c001e71a83" title="2019 HFA/ESC专家共识:心力衰竭的药物治疗、程序、设备以及患者管理(更新版)" target=_blank>2019 HFA/ESC专家共识:心力衰竭的药物治疗、程序、设备以及患者管理(更新版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=02ae61c001e7102e" title="中国成人心力衰竭超声心动图规范化检查专家共识" target=_blank>中国成人心力衰竭超声心动图规范化检查专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=9b22a1c001e7062f" title="2019 HFA/ESC专家共识:心力衰竭的药物治疗、程序、设备以及患者管理(更新版)" target=_blank>2019 HFA/ESC专家共识:心力衰竭的药物治疗、程序、设备以及患者管理(更新版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=bf8c91c001e6a5d0" title="《心力衰竭合理用药指南(第2版)》" target=_blank>《心力衰竭合理用药指南(第2版)》</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD" target=_blank>有关心力衰竭更多指南</a></ul>, tagList=[TagDto(tagId=335, tagName=心力衰竭), TagDto(tagId=2665, tagName=住院患者), TagDto(tagId=1115, tagName=风险评估)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5898, appHits=524, showAppHits=6, pcHits=3257, showPcHits=3474, likes=78, shares=22, comments=4, approvalStatus=1, publishedTime=Wed Oct 02 19:00:55 CST 2019, publishedTimeString=2019-09-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Oct 02 19:00:55 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:30:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ACC专家共识决策路径:心力衰竭住院患者的风险评估,管理和临床路径)])
2019 ACC专家共识决策路径:心力衰竭住院患者的风险评估,管理和临床路径
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=948835, encodeId=693f94883538, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de92506232, createdName=124acfe0m20暂无昵称, createdTime=Tue Mar 16 22:11:06 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911154, encodeId=a35e911154e1, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/8f6199f1b6d44cbc85ab0ca32d15a198/7c0ca6363f1644d09fdd562f07ed78d0.jpg, createdBy=5fc04378756, createdName=14078833m07暂无昵称, createdTime=Sat Dec 26 21:55:34 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812591, encodeId=b502812591d9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c615403200, createdName=ms8000000618836174, createdTime=Sun Aug 23 23:50:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373867, encodeId=92593e3867bd, content=最好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTID49TgGdY2NC8zEWicukpHRFM6nut1qzFgzI8Sex7byVrSqXZtl7iaP5jaMdPeJWvwfsPgibXlUpjBw/132, createdBy=f9712474385, createdName=oc.w, createdTime=Sun Oct 13 22:15:12 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
    2021-03-16 124acfe0m20暂无昵称

    很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=948835, encodeId=693f94883538, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de92506232, createdName=124acfe0m20暂无昵称, createdTime=Tue Mar 16 22:11:06 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911154, encodeId=a35e911154e1, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/8f6199f1b6d44cbc85ab0ca32d15a198/7c0ca6363f1644d09fdd562f07ed78d0.jpg, createdBy=5fc04378756, createdName=14078833m07暂无昵称, createdTime=Sat Dec 26 21:55:34 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812591, encodeId=b502812591d9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c615403200, createdName=ms8000000618836174, createdTime=Sun Aug 23 23:50:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373867, encodeId=92593e3867bd, content=最好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTID49TgGdY2NC8zEWicukpHRFM6nut1qzFgzI8Sex7byVrSqXZtl7iaP5jaMdPeJWvwfsPgibXlUpjBw/132, createdBy=f9712474385, createdName=oc.w, createdTime=Sun Oct 13 22:15:12 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
    2020-12-26 14078833m07暂无昵称

    很实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=948835, encodeId=693f94883538, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de92506232, createdName=124acfe0m20暂无昵称, createdTime=Tue Mar 16 22:11:06 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911154, encodeId=a35e911154e1, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/8f6199f1b6d44cbc85ab0ca32d15a198/7c0ca6363f1644d09fdd562f07ed78d0.jpg, createdBy=5fc04378756, createdName=14078833m07暂无昵称, createdTime=Sat Dec 26 21:55:34 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812591, encodeId=b502812591d9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c615403200, createdName=ms8000000618836174, createdTime=Sun Aug 23 23:50:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373867, encodeId=92593e3867bd, content=最好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTID49TgGdY2NC8zEWicukpHRFM6nut1qzFgzI8Sex7byVrSqXZtl7iaP5jaMdPeJWvwfsPgibXlUpjBw/132, createdBy=f9712474385, createdName=oc.w, createdTime=Sun Oct 13 22:15:12 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
    2020-08-23 ms8000000618836174

    很实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=948835, encodeId=693f94883538, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de92506232, createdName=124acfe0m20暂无昵称, createdTime=Tue Mar 16 22:11:06 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911154, encodeId=a35e911154e1, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/8f6199f1b6d44cbc85ab0ca32d15a198/7c0ca6363f1644d09fdd562f07ed78d0.jpg, createdBy=5fc04378756, createdName=14078833m07暂无昵称, createdTime=Sat Dec 26 21:55:34 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812591, encodeId=b502812591d9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c615403200, createdName=ms8000000618836174, createdTime=Sun Aug 23 23:50:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373867, encodeId=92593e3867bd, content=最好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTID49TgGdY2NC8zEWicukpHRFM6nut1qzFgzI8Sex7byVrSqXZtl7iaP5jaMdPeJWvwfsPgibXlUpjBw/132, createdBy=f9712474385, createdName=oc.w, createdTime=Sun Oct 13 22:15:12 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
    2019-10-13 oc.w

    最好的指南

    0